ANNA DSB Faces Industry Concerns Over ISINs for OTC Derivatives

Licensing and user agreements surrounding ANNA's service burea for OTC derivative ISIN numbers have sparked fireworks over recent months as the service goes live ahead of Mifid II. Joanne Faulkner investigates.

Because many of these derivatives have never needed an ISIN before, the new regulations have required the construction of a fresh infrastructure to facilitate the near-real-time allocation of ISINs upon application by a user. The Association of National Numbering Agencies Derivatives Service Bureau (ANNA DSB) aims to fulfil this task, and will be the first numbering agency designed to operate globally.

The DSB will operate on a cost-recovery basis, and will charge fees—up to €65,000 per annum

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Nasdaq reshuffles tech divisions post-Adenza

Adenza is now fully integrated into the exchange operator’s ecosystem, bringing opportunities for new business and a fresh perspective on how fintech fits into its strategy.

Deutsche Börse democratizes data with Marketplace offering

Deutsche Börse Group is set to unveil its Marketplace, a one-stop data shop designed to simplify and streamline data acquisition and consumption for its clients, while also surfacing data from across the firm to its own users. Jan Stiebing and Sven…

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here